Multiorgan biological age
Biomarker1 paper1 finding
- Human trial1
Interventions
1Semaglutide
downin humans1
1 study
Semaglutide
downin humans1
Semaglutide decreases multiorgan biological age in humans (reductions of 1 to 4 years).
“reductions of 1 to 4 years across kidney, brain, pancreas, lung and multiorgan clocks”
Human trialup to 156 weeksn = 10,052
Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials · Research Square · 22 Sep 2026 · Preprint
Latest
1Research SquareHuman trialPreprint